North America GMP testing service market is projected to grow by 7.4% annually in the forecast period and reach $ 2,894.7 million by 2031, driven by the growing pharmaceutical industry and the increasing need for developing novel drugs and medical devices, the rising outsourcing activities for quality assurance, and the fast-growing cosmetics industry and food & beverage industry.
Highlighted with 21 tables and 38 figures, this 92-page report “North America GMP Testing Service Market 2021-2031 by Service Type (Product/Process Validation Testing, Bioanalytical Services, Packaging and Shelf-life Testing, Others), Service Provider (In-house Facilities, Outsourced Facilities), End User (Pharmaceutical and Biopharmaceutical Companies, Medical Device Companies, Cosmetic Companies, Food and Beverage Companies, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America GMP testing service market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and the Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify North America GMP testing service market in every aspect of the classification from perspectives of Service Type, Service Provider, End User, and Country.
Based on Service Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Product/Process Validation Testing
• Bioanalytical Services
• Packaging and Shelf-life Testing
• Other Service Types
Based on Service Provider, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• In-house Facilities
• Outsourced Facilities
By End User, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Pharmaceutical and Biopharmaceutical Companies
• Medical Device Companies
• Cosmetic Companies
• Food and Beverage Companies
• Other End Users
Geographically, the following national/local markets are fully investigated:
• U.S.
• Canada
• Mexico
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Service Type, Service Provider, and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Almac Group
Charles River Laboratories
Covance Inc.
Eurofins Scientific
Intertek Group Plc
Microchem Laboratory
Nelson Laboratories LLC
North American Science Associates Inc.
Pace Analytical
PPD Inc.
Sartorius AG
Wuxi AppTec
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
